NEW YORK, Oct. 31, 2019 /PRNewswire/ -- Klara (www.klara.com), the New York based leader in secure patient communication, is proud to announce a new partn

SAN DIEGO, Oct. 31, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the third quarter 2019, prior to the market open on Tue

SLOUGH, England and RICHMOND, Va., Oct. 31, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its Q3/YTD 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at

COPENHAGEN, Denmark, Oct. 31, 2019 /PRNewswire/ -- CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform. The EU grant is for an SME

NEW BRUNSWICK, N.J., Oct. 31, 2019 /PRNewswire/ -- The government of the Democratic Republic of the Congo (DRC) has decided to use the investigational Ebola vaccine regimen currently being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson as part of an expanded public health initiative to help contain the cou

MARINA DEL REY, Calif., Oct. 31, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today issued the following letter to shareholders. The letter has been made available to all existing shareholders with the

· Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date ·· Third Quarter Adjusted EBITDA - $7.8 million and $18.7 million year-to-date ·

NEWARK, Calif., Oct. 31, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced it has entered into a four-year debt facility with MidCap Financial (MidCap), the lead agent, and Silicon Valley Bank (SVB).The lenders under the debt facility will make available to Protagonist an aggregate principal amount up to

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- L'Oréal USA today announced the recipients of the 2019 For Women in Science (FWIS) Fellowship, which annually awards five female postdoctoral scientists grants of $60,000 each to advance their research. This is the 16th year of the program, which to date has

BOSTON, Oct. 31, 2019 /PRNewswire/ -- TetraScience, developers of the industry's first cloud-based data integration platform for life sciences R&D, today announced it has secured a strategic investment from Waters Corporation (NYSE: WAT), the world's leading specialty measurement company. Waters Corporation joins a roster of leading venture investors in TetraSci